Evaluation of Surgical Treatment of Colorectal Liver metastasis
Mohammed Mohammed Abdou Hamoda;
Abstract
Colorectal cancer is the 3rd leading cause of cancer related deaths in males and females. The liver is the most common site of distant disease in colorectal cancer and approximately 60% of patients will develop liver metastases at some point during the course of their disease.
Metastatic disease of the liver was considered a lethal disease. Untreated metastatic colorectal carcinoma has a median survival of 6 to 9 months. Also using chemotherapy in the treatment of multiple colorectal cancer metastases was not so successful with median survival rate of 16.2 months.
This study reviewed the history and evolution of therapies used for the management of metastatic colorectal cancer to the liver.
Improvements in surgical technique, imaging and systemic therapy have led to expand the criteria of resectability; actually, the only sure contraindication for hepatic resection in management of
Metastatic disease of the liver was considered a lethal disease. Untreated metastatic colorectal carcinoma has a median survival of 6 to 9 months. Also using chemotherapy in the treatment of multiple colorectal cancer metastases was not so successful with median survival rate of 16.2 months.
This study reviewed the history and evolution of therapies used for the management of metastatic colorectal cancer to the liver.
Improvements in surgical technique, imaging and systemic therapy have led to expand the criteria of resectability; actually, the only sure contraindication for hepatic resection in management of
Other data
| Title | Evaluation of Surgical Treatment of Colorectal Liver metastasis | Other Titles | تقييم الاستئصال الجراحي لأورام الكبد الثانوية المنتشرة من أورام القولون والمستقيم | Authors | Mohammed Mohammed Abdou Hamoda | Issue Date | 2017 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.